Abstract
Nearly all diseases can be caused by different combinations of exposures. Yet, most epidemiological studies focus on the causal effect of a single exposure on an outcome. We present the Causes of Outcome Learning (CoOL) approach, which seeks to identify combinations of exposures (which can be interpreted causally if all causal assumptions are met) that could be responsible for an increased risk of a health outcome in population sub-groups. The approach allows for exposures acting alone and in synergy with others. It involves (a) a pre-computational phase that proposes a causal model; (b) a computational phase with three steps, namely (i) analytically fitting a non-negative additive model, (ii) decomposing risk contributions, and (iii) clustering individuals based on the risk contributions into sub-groups based on the predefined causal model; and (c) a post-computational phase on hypothesis development and validation by triangulation on new data before eventually updating the causal model. The computational phase uses a tailored neural network for the non-negative additive model and Layer-wise Relevance Propagation for the risk decomposition through this model. We demonstrate the approach on simulated and real-life data using the R package ‘CoOL’. The presentation is focused on binary exposures and outcomes but can be extended to other measurement types. This approach encourages and enables epidemiologists to identify combinations of pre-outcome exposures as potential causes of the health outcome of interest. Expanding our ability to discover complex causes could eventually result in more effective, targeted, and informed interventions prioritized for their public health impact.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AR was supported by an international postdoc grant by the Independent Research Fund Denmark (9034-00006B). PD was supported by a research grant from the Danish Diabetes Academy funded by the Novo Nordisk Foundation. LA, SL, and WS are supported by the German Ministry for Education and Research as BIFOLD (refs. 01IS18025A and 01IS18037A) and TraMeExCo (ref. 01IS18056A). OAA was supported by a grant (R01EB0276502) from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a grant (UL1TR001881) from the National Center for Advancing Translational Sciences (NCATS), both at the National Institutes of Health (NIH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The real life data is provided by the Center of Disease Control and Prevention (CDC), USA.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: None.
Funding: AR was supported by an international postdoc grant by the Independent Research Fund Denmark (9034-00006B). PD was supported by a research grant from the Danish Diabetes Academy funded by the Novo Nordisk Foundation. LA, SL, and WS are supported by the German Ministry for Education and Research as BIFOLD (refs. 01IS18025A and 01IS18037A) and TraMeExCo (ref. 01IS18056A). OAA was supported by a grant (R01EB0276502) from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a grant (UL1TR001881) from the National Center for Advancing Translational Sciences (NCATS), both at the National Institutes of Health (NIH).
Data Availability
Simulated data can be generated using the provided R package "CoOL". Access to the real life data is explained in the Supplementary Material page 21.
